About: Coronary and structural heart disease interventions during COVID-19 pandemic: A road map for clinicians and health care delivery systems

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Coronary and structural heart disease interventions during COVID-19 pandemic: A road map for clinicians and health care delivery systems Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Coronary and structural heart disease interventions during COVID-19 pandemic: A road map for clinicians and health care delivery systems
Creator	Scott, Thomas Agarwal, Agarwal, Shikhar Bauch, Terry Bernardi, Mark Blankenship, James Casale, Alfred Green, Sandy Harjai, Kishore Harostock, Michael Ierovante, Nicholas Mascarenhas, Vernon Matsumura, Martin Nawaz, Yassir Singh, Deepak Stella, Joseph Vijayaraman, Pugazhendi Yost, Gregory
Source	Elsevier; Medline; PMC
abstract	BACKGROUND: Because of the COVID-19 pandemic, cath labs have had to modify their workflow for elective and urgent patients. METHODS: We surveyed 16 physicians across 3 hospitals in our healthcare system to address COVID-19 related concerns in the management of interventional and structural heart disease patients, and to formulate system wide criteria for deferring cases till after the pandemic. RESULTS: Our survey yielded common concerns centered on the need to protect patients, cath lab staff and physicians from unnecessary exposure to COVID-19; for COVID-19 testing prior to arrival to the cath lab; for clear communication between the referring physician and the interventionalist; but there was initial uncertainty among physicians regarding the optimal management of ST elevation myocardial infarction (STEMI; percutaneous coronary intervention versus thrombolytics). Patients with stable angina and hemodynamically stable acute coronary syndromes were deemed suitable for initial medical management, except when they had large ischemic burden. Most transcatheter aortic valve implantations (TAVI) were felt appropriate for postponement except in symptomatic patients with aortic valve area <0.5 cm(2) or recent hospitalization for heart failure (HF). Most percutaneous mitral valve repair (pMVR) procedures were felt appropriate for postponement except in patients with HF. All left atrial appendage closure (LAAC) and patent foramen ovale (PFO)/atrial septal defect (ASD) closure procedures were felt appropriate for postponement. CONCLUSION: Our survey of an experienced team of clinicians yielded concise guidelines to direct the management of CAD and structural heart disease patients during the initial phases of the COVID-19 pandemic.
has issue date	2020-06-10(xsd:dateTime)
bibo:doi	10.1016/j.carrev.2020.06.013
bibo:pmid	32586744
has license	no-cc
sha1sum (hex)	9cd0ab88d6d9700c443f577a85d2f4b20294926b
schema:url	https://doi.org/10.1016/j.carrev.2020.06.013
resource representing a document's title	Coronary and structural heart disease interventions during COVID-19 pandemic: A road map for clinicians and health care delivery systems
has PubMed Central identifier	PMC7286249
has PubMed identifier	32586744
schema:publication	Cardiovasc Revasc Med
resource representing a document's body	covid:9cd0ab88d6d9700c443f577a85d2f4b20294926b#body_text
is schema:about of	named entity 'Road Map' named entity 'A Road' named entity 'ELECTIVE' named entity 'N A' named entity 'modify' named entity 'Abstract' named entity 'Health Care Delivery' named entity 'Structural Heart Disease' named entity 'cardiac surgeons' named entity 'COVID-19 pandemic' named entity 'thrombolytics' named entity 'PCI' named entity 'thrombolytics' named entity 'integrated health' named entity 'myocarditis' named entity 'STEMI' named entity 'COVID-19' named entity 'coronary artery disease' named entity 'cardiac surgeons' named entity 'STEMI' named entity 'PPE' named entity 'cardiovascular events' named entity 'non-invasive' named entity 'myocarditis' named entity 'cath lab' named entity 'COVID-19' named entity 'heart disease' named entity 'coronary occlusion' named entity 'left atrial appendage' named entity 'CAD' named entity 'STEMI' named entity 'cath lab' named entity 'cardiologists' named entity 'anticoagulation' named entity 'COVID-19' named entity 'STEMI' named entity 'heart diseases' named entity 'thrombolytics' named entity 'ISCHEMIA' named entity 'prognosis' named entity 'angina' named entity 'ischemic' named entity 'CAD' named entity 'healthcare delivery' named entity 'EKG' named entity 'cardiologists' named entity 'STEMI' named entity 'thrombolytics' named entity 'cardiologists' named entity 'ischemic' named entity 'cath lab' named entity 'infection' named entity 'STEMI' named entity 'PPE' named entity 'primary PCI' named entity 'CAD' named entity 'aortic stenosis' named entity 'interventional cardiologists' named entity 'point-of-care testing' named entity 'patent foramen ovale' named entity 'personal protective equipment' named entity 'COVID-19' named entity 'CAD' named entity 'STEMI'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software